By gene silencing of the NFκB subunit p65, we found that inhibition of CXCL-1 and -2 expression (CXCL-1: chemokine C-X-C motif ligand 1) by Curcumin in breast cancer cells is mediated through NFκB [15]. This evidence concerns the gene NFKB1 and breast carcinoma.